Omega Therapeutics (OMGA) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free OMGA Stock Alerts $2.41 +0.03 (+1.26%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 2:28 AM | americanbankingnews.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. Raised by Analyst (NASDAQ:OMGA)May 15 at 7:49 AM | marketbeat.comQ3 2024 EPS Estimates for Omega Therapeutics, Inc. Raised by HC Wainwright (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for Omega Therapeutics in a report released on Monday, May 13th. HC Wainwright analyst R. Burns now forecasts that the company will post earninMay 15 at 6:12 AM | americanbankingnews.comBrokers Set Expectations for Omega Therapeutics, Inc.'s Q3 2025 Earnings (NASDAQ:OMGA)May 15 at 3:38 AM | americanbankingnews.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by HC WainwrightMay 14, 2024 | marketbeat.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Expected to Post Q3 2025 Earnings of ($0.29) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Investment analysts at HC Wainwright issued their Q3 2025 earnings per share (EPS) estimates for Omega Therapeutics in a research note issued on Monday, May 13th. HC Wainwright analyst R. Burns forecasts that the company will post earnings peMay 13, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial PerformanceMay 13, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and set a $12.00 price target on shares of Omega Therapeutics in a report on Monday.May 12, 2024 | americanbankingnews.comAnalysts Set Expectations for Omega Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:OMGA)May 10, 2024 | marketbeat.comEquities Analysts Offer Predictions for Omega Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Equities research analysts at Chardan Capital issued their FY2025 earnings per share estimates for shares of Omega Therapeutics in a research note issued on Tuesday, May 7th. Chardan Capital analyst K. Nakae anticipates that the company willMay 9, 2024 | americanbankingnews.comQ2 2024 Earnings Estimate for Omega Therapeutics, Inc. Issued By Wedbush (NASDAQ:OMGA)May 9, 2024 | americanbankingnews.comChardan Capital Reiterates "Buy" Rating for Omega Therapeutics (NASDAQ:OMGA)May 8, 2024 | globenewswire.comOmega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersMay 8, 2024 | americanbankingnews.comOmega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by WedbushMay 7, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Receives "Buy" Rating from Chardan CapitalChardan Capital reiterated a "buy" rating and issued a $7.00 target price on shares of Omega Therapeutics in a research report on Tuesday.May 7, 2024 | markets.businessinsider.com4 Analysts Have This To Say About Omega TherapeuticsMay 7, 2024 | finance.yahoo.comOmega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In LineMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical TrialsMay 6, 2024 | markets.businessinsider.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 6, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Rating Reiterated by WedbushWedbush reiterated an "outperform" rating and issued a $12.00 price objective on shares of Omega Therapeutics in a research report on Monday.May 6, 2024 | investorplace.comOMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024May 6, 2024 | globenewswire.comOmega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressMay 2, 2024 | marketbeat.comOmega Therapeutics, Inc. (NASDAQ:OMGA) Forecasted to Post Q1 2024 Earnings of ($0.38) Per ShareOmega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Analysts at HC Wainwright increased their Q1 2024 EPS estimates for Omega Therapeutics in a research report issued to clients and investors on Tuesday, April 30th. HC Wainwright analyst R. Burns now forecasts that the company will post earninApril 30, 2024 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Omega Therapeutics (NASDAQ:OMGA)HC Wainwright reissued a "buy" rating and issued a $12.00 target price on shares of Omega Therapeutics in a research report on Tuesday.April 23, 2024 | globenewswire.comOmega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingApril 9, 2024 | globenewswire.comOmega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlApril 4, 2024 | marketbeat.comOmega Therapeutics, Inc. to Post FY2024 Earnings of ($1.31) Per Share, Chardan Capital Forecasts (NASDAQ:OMGA)Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Research analysts at Chardan Capital upped their FY2024 EPS estimates for shares of Omega Therapeutics in a research note issued to investors on Monday, April 1st. Chardan Capital analyst K. Nakae now anticipates that the company will earn ($April 3, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Earns "Overweight" Rating from Piper SandlerPiper Sandler reissued an "overweight" rating and issued a $9.00 price objective (down from $10.00) on shares of Omega Therapeutics in a report on Wednesday.April 1, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Price Target Cut to $7.00Chardan Capital dropped their target price on shares of Omega Therapeutics from $12.00 to $7.00 and set a "buy" rating for the company in a research report on Monday.March 31, 2024 | seekingalpha.comOmega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy'March 29, 2024 | finance.yahoo.comWe Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth CarefullyMarch 29, 2024 | investorplace.comOMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023March 28, 2024 | globenewswire.comOmega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateMarch 16, 2024 | finance.yahoo.comOMGA Apr 2024 12.500 callMarch 12, 2024 | markets.businessinsider.comIntrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem PandyaMarch 6, 2024 | globenewswire.comOmega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024March 1, 2024 | marketbeat.comOracle Investment Management Inc. Sells 147,449 Shares of Omega Therapeutics, Inc. (NASDAQ:OMGA)Oracle Investment Management Inc. trimmed its position in shares of Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) by 74.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,000 shares of the company's stock afteFebruary 17, 2024 | marketbeat.comOmega Therapeutics (NASDAQ:OMGA) Shares Up 0.9%Omega Therapeutics (NASDAQ:OMGA) Stock Price Up 0.9%January 26, 2024 | benzinga.comHow Is The Market Feeling About Omega Therapeutics?January 16, 2024 | seekingalpha.comOmega Therapeutics: The Next Weight Loss Drug RunnerJanuary 6, 2024 | morningstar.comOmega Therapeutics Inc OMGAJanuary 5, 2024 | finance.yahoo.comNovo Nordisk (NVO) Up on $1.1B Research Deals With 2 BiotechsJanuary 5, 2024 | finance.yahoo.comOmega (OMGA) Up 95% on Obesity Drug Deal With Novo NordiskJanuary 4, 2024 | msn.comOmega (NASDAQ:OMGA) Skyrockets After Research Deal With Novo NordiskJanuary 4, 2024 | realmoney.thestreet.comOmega collaboration with Novo Nordisk 'validation' of OEG platform, says WedbushJanuary 4, 2024 | fool.comWhy Novo Nordisk Stock Crushed the Market TodayJanuary 4, 2024 | ca.finance.yahoo.comOMGA Feb 2024 2.500 callJanuary 4, 2024 | markets.businessinsider.comFamed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic DiseasesJanuary 4, 2024 | finance.yahoo.comNovo Nordisk enters research partnerships with biotech firmsJanuary 4, 2024 | finance.yahoo.comNovo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In ObesityJanuary 4, 2024 | investorplace.comWhy Is Omega Therapeutics (OMGA) Stock Up 111% Today? Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here OMGA Media Mentions By Week OMGA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMGA News Sentiment▼0.650.44▲Average Medical News Sentiment OMGA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMGA Articles This Week▼162▲OMGA Articles Average Week Get Omega Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Molecular Partners News Today Karyopharm Therapeutics News Today Scilex News Today aTyr Pharma News Today BioAtla News Today Vigil Neuroscience News Today Sangamo Therapeutics News Today bluebird bio News Today DBV Technologies News Today Cardiol Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMGA) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
